Learn how Cmax and AUC determine if generic drugs are truly equivalent to brand names. We explain peak concentration, total exposure, and the 80-125% regulatory rule in simple terms.
Discover the key differences between authorized generics and traditional generics. Learn how composition, FDA approval pathways, and market timing impact your medication choices and costs.
Pharmacists use the FDA's Orange Book to verify that generic drugs are therapeutically equivalent to brand-name medications. This process ensures safety, legality, and effectiveness - protecting patients and the system.
Partial AUC is a key tool in bioequivalence testing for complex generic drugs, helping regulators ensure safe and effective absorption patterns beyond traditional metrics like Cmax and total AUC.
